Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKesson
Boehringer Ingelheim
Accenture
Farmers Insurance
Fuji

Generated: March 19, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018655

« Back to Dashboard

NDA 018655 describes NORPACE CR, which is a drug marketed by Gd Searle Llc and is included in one NDA. It is available from two suppliers. Additional details are available on the NORPACE CR profile page.

The generic ingredient in NORPACE CR is disopyramide phosphate. There are nineteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.
Summary for 018655
Tradename:NORPACE CR
Applicant:Gd Searle Llc
Ingredient:disopyramide phosphate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018655
Medical Subject Heading (MeSH) Categories for 018655
Suppliers and Packaging for NDA: 018655
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORPACE CR disopyramide phosphate CAPSULE, EXTENDED RELEASE;ORAL 018655 NDA G.D. Searle LLC Division of Pfizer Inc 0025-2732 0025-2732-31 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0025-2732-31)
NORPACE CR disopyramide phosphate CAPSULE, EXTENDED RELEASE;ORAL 018655 NDA G.D. Searle LLC Division of Pfizer Inc 0025-2732 0025-2732-34 100 CAPSULE, EXTENDED RELEASE in 1 BOX, UNIT-DOSE (0025-2732-34)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrengthEQ 100MG BASE
Approval Date:Jul 20, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrengthEQ 150MG BASE
Approval Date:Jul 20, 1982TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Moodys
Teva
Chinese Patent Office
Mallinckrodt
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.